Market Overview

ANI Pharma (NASDAQ: ANIP)

73.67 +0.81 (1.11%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2020
Pre-Market
EPS:
REV:




Q1 2020
Pre-Market
EPS:
REV:
1.3
52.887M



Q4 2019
Pre-Market
EPS:
REV:
1.32
57.122M



Q3 2019
Pre-Market
EPS:
REV:
1.29
50.703M



Q2 2019
Pre-Market
EPS:
REV:
1.13
47.268M
1.28
55.2M
1.44
54.357M
12.5%
-1.53%
Q1 2019
Pre-Market
EPS:
REV:
1.32
46.483M
1.05
50.57M
1.3
52.887M
23.81%
4.58%
Q4 2018
Pre-Market
EPS:
REV:
1.08
47.286M
1.24
53.48M
1.32
57.122M
6.45%
6.81%
Q3 2018
Pre-Market
EPS:
REV:
1.11
48.164M
1.17
50.96M
1.29
50.703M
10.26%
-0.5%
Q2 2018
Pre-Market
EPS:
REV:
0.98
44.764M
1.34
51.42M
1.13
47.268M
-15.67%
-8.07%
Q1 2018
Pre-Market
EPS:
REV:
0.74
36.628M
1.28
49.93M
1.32
46.483M
3.13%
-6.9%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!